A Look At Definium Therapeutics (DFTX) Valuation After Its Recent Name Change And Share Price Momentum [Yahoo! Finance]
Definium Therapeutics, Inc. - Common Shares (DFTX)
Company Research
Source: Yahoo! Finance
Definium Therapeutics (DFTX) has drawn fresh attention after a name change from Mind Medicine in January 2026, as investors reassess a biopharma focused on brain health disorders and late stage clinical assets. The stock recently closed at US$17.79, with a market value of about US$1.8b and a mixed return profile that includes gains over the past month and past 3 months alongside periods of weaker long term performance. See our latest analysis for Definium Therapeutics. Recent trading has cooled slightly, with a 1 day share price return of 1.71% and a 7 day share price return of 1.66%. However, the 90 day share price return of 32.46% and 1 year total shareholder return of 162.39% indicate momentum that has reshaped how the market is pricing Definium Therapeutics after a weak 5 year total shareholder return of 47.98%. If you are looking beyond Definium Therapeutics in the brain health space, this could be a useful moment to scan for other healthcare names using the 36 healthcar
Show less
Read more
Impact Snapshot
Event Time:
DFTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DFTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DFTX alerts
High impacting Definium Therapeutics, Inc. - Common Shares news events
Weekly update
A roundup of the hottest topics
DFTX
News
- Definium Therapeutics to Host Investor and Analyst Day in New York on April 22, 2026Business Wire
- Definium Therapeutics Inc (DFTX) Says Cash Enough to Fund Operations into 2028 [Yahoo! Finance]Yahoo! Finance
- This $6 Million Bet Adds a Brain Health Biotech to Portfolio Dominated by Clinical Stage Names [Yahoo! Finance]Yahoo! Finance
- Definium Therapeutics Teases Phase III DT120 Data for Anxiety, Depression at Leerink Conference [Yahoo! Finance]Yahoo! Finance
- Definium Therapeutics Announces New Employee Inducement GrantsBusiness Wire
DFTX
Earnings
- 2/26/26 - Miss
DFTX
Sec Filings
- 3/26/26 - Form 4
- 3/26/26 - Form 4
- 3/26/26 - Form 4
- DFTX's page on the SEC website